Skip to content
6-K

Foreign Interim / Material

BioLineRx Ltd. BLRX

0001178913-25-002883

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 2.37B sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.29B sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.2B sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.14B sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$2.77M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$25.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $7.19M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $10.44M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $9.62M
Cash And Equivalents Q2 2025 · Dec 31, 2023 $4.26M
Stockholders Equity Q2 2025 · Jun 30, 2025 $20.07M
Stockholders Equity Q2 2025 · Dec 31, 2024 $13.46M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $13.89M
Stockholders Equity Q2 2025 · Dec 31, 2023 $13.22M
Current Liabilities Q2 2025 · Jun 30, 2025 $15.48M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.41M
Total Liabilities Q2 2025 · Jun 30, 2025 $23.2M
Total Liabilities Q2 2025 · Dec 31, 2024 $25.45M
Current Assets Q2 2025 · Jun 30, 2025 $31.86M
Current Assets Q2 2025 · Dec 31, 2024 $27.1M
Total Assets Q2 2025 · Jun 30, 2025 $43.27M
Total Assets Q2 2025 · Dec 31, 2024 $38.91M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Sga Expense Q2 2025 · Jun 30, 2025 $209K
Sga Expense Q2 2025 · Jun 30, 2025 $1.2M
Sga Expense Q2 2025 · Jun 30, 2024 $1.63M
Sga Expense Q2 2025 · Jun 30, 2024 $3.02M
Rd Expense Q2 2025 · Jun 30, 2025 $2.33M
Rd Expense Q2 2025 · Jun 30, 2025 $3.95M
Rd Expense Q2 2025 · Jun 30, 2024 $2.23M
Rd Expense Q2 2025 · Jun 30, 2024 $4.72M
Net Income Q2 2025 · Jun 30, 2025 −$3.94M
Net Income Q2 2025 · Jun 30, 2025 $1.19M
Net Income Q2 2025 · Jun 30, 2024 $484K
Net Income Q2 2025 · Jun 30, 2024 −$212K
Operating Income Q2 2025 · Jun 30, 2025 −$2.3M
Operating Income Q2 2025 · Jun 30, 2025 −$4.69M
Operating Income Q2 2025 · Jun 30, 2024 −$5.77M
Operating Income Q2 2025 · Jun 30, 2024 −$10.6M
Gross Profit Q2 2025 · Jun 30, 2025 $232K
Gross Profit Q2 2025 · Jun 30, 2025 $453K
Gross Profit Q2 2025 · Jun 30, 2024 $4.5M
Gross Profit Q2 2025 · Jun 30, 2024 $9.9M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $72K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $106K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $897K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.35M
Revenue Q2 2025 · Jun 30, 2025 $304K
Revenue Q2 2025 · Jun 30, 2025 $559K
Revenue Q2 2025 · Jun 30, 2024 $5.39M
Revenue Q2 2025 · Jun 30, 2024 $12.25M